Company: INMB
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001213900-25-033742
Chunk: 33

Company: Inmune Bio, Inc.
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 33
---
 executive officers; •Periodically reviewing and making recommendations to the Board of Directors with respect to compensation of non -employeedirectors; •Reviewing and approving corporate goals and objectives relevant to chief executive officer compensation, evaluating the chief executive officer’s performance in light of those goals and objectives, and setting the chief executive officer’s compensation levels based on this evaluation; •Reviewing competitive practices and trends to determine the adequacy of the executive compensation program; •Approving and overseeing incentive compensation and equity -basedplans for executive officers that are subject to Board of Directors approval; •Making recommendations to the Board as to the Company’s compensation philosophy and overseeing the development and implementation of compensation programs; •Periodically reviewing and making recommendations to the Board of Directors with respect to compensation of non -employeedirectors; and •Reviewing and approving corporate goals and objectives relevant to chief executive officer compensation, evaluating the chief executive officer’s performance in light of those goals and objectives, and setting the chief executive officer’s compensation levels based on this evaluation. When appropriate, the compensation committee may, in carrying out its responsibilities, form and delegate authority to subcommittees. The chief executive officer plays a role in determining the compensation of our other executive officers by evaluating the performance of those executive officers. The chief executive officer’s evaluations are then reviewed by the compensation committee. This process leads to a recommendation for any changes in salary, bonus terms and equity awards, if any, based on performance, which recommendations are then reviewed and approved by the compensation committee. The compensation committee has the authority, at the Company’s expense, to select, retain, terminate and set the fees and other terms of the Company’s relationship with any outside advisors who assist it in carrying out its responsibilities, including compensation consultants or independent legal counsel. The Board of Directors has adopted a written charter setting forth the authority and responsibilities of the compensation committee. The compensation committee consists of Scott Juda, J.D., Timothy Schroeder and Kelly Ganjei. Timothy Schroeder is the chairman of the compensation committee. The Board of Directors has affirmatively determined that each member of the compensation committee meets the additional independence criteria applicable to compensation committee members under SEC rules and the Nasdaq Stock Market LLC. During 2024, the compensation committee met 2 times. 23 Compensation Committee Interlocks and Insider Participation No member of the compensation committee will be a current or former executive officer or employee of ours or any of our subsidiaries. None of our executive officers serves as a member of the Board of Directors or compensation committee of any company that